Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-21

FDA Approved: LAMIVUDINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original generic application for lamivudine from Rising Pharma Holdings, Inc., making a generic option available for HIV-1 infection in combina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)